Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.
The UK NSC is very excited by the news, announced on International Men’s Day, of a major new prostate cancer screening trial backed by £42 million of funding from Prostate Cancer UK and the government.
Please complete a short survey to help us make sure the UK NSC web pages are fit for purpose and meet the needs of all our stakeholders.
The NHS in England will this month start inviting people at lower risk of diabetic retinopathy for diabetic eye screening every 2 years instead of every year.
The UK NSC is consulting on whether providers and commissioners can safely use digital pathology in existing cancer screening programmes, excluding cytology, as an alternative to light microscopy.
Wales has followed Scotland and Northern Ireland in implementing the UK NSC's recommendation for a low risk diabetic eye screening pathway.
A summary note has been published of the latest meeting of the UK National Screening Committee's Blood Spot Task Group when members were updated on progress on 4 of its 5 core projects.
Apply for one of 12 exciting vacancies in the expert reference groups that support the UK National Screening Committee.